With contract manufacturing work in high demand, Netherlands CDMO lands new investment
A Dutch CDMO is looking to build upon its success over the past few years, and a recently-announced investment will pave the way.
An undisclosed investment from Gimv, supported by shareholders Pharming Group N.V. and Mibiton, will be used to accelerate BioConnection’s production capacity, quality control and innovation. BioConnection will use Gimv’s life science network as future leverage, the statement said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.